Skip to main content

Jeffrey P. Schultz




Jeff is a versatile corporate and securities lawyer who steers clients through critical transactions. His repertoire includes debt and equity security financings, IPOs and other types of public offerings, private investment in public equity (PIPE) transactions, mergers and acquisitions, and strategic deals and agreements. Domestic and foreign public companies seek his assistance with public and private financings, SEC compliance, NASDAQ and NYSE compliance, corporate governance and general counseling. He also advises issuers and underwriters during IPOs of special purpose acquisition companies (SPACs). Technology, life sciences, media, retail, restaurants and hospitality, consumer products, and entertainment companies are on his client roster.

Jeffrey is involved with all aspects of corporate, commercial, and securities law matters. He regularly advises domestic and non-US clients on a broad range of US and international corporate transactions, including public and private debt and equity security financings, mergers and acquisitions, joint ventures, and strategic alliances.

He prepares securities filings, reports and registration statements, including foreign private issuers, and has been involved in all aspects of mergers, acquisitions, and corporate restructurings. Recently, he has represented both issuers and underwriters in connection with initial public offerings by a number of special purpose acquisition companies (SPACs) in both the US and the UK, and has provided counsel with regard to their respective ongoing regulatory compliance.

During law school, he was an editor of the Boston University Law Review.

Case Studies

Breaking Down the SPAC Surge Report Cover Mintz Case Study
Mintz analyzed PitchBook data to produce an in-depth report on the record rise in special purpose acquisition company (SPAC) fundraising in the US since 2020 and the recent increase in SPAC merger activity. We also explore how SPACs could evolve and litigation challenges to SPAC IPOs and transactions.
Read less


SPAC Chat Ep. 5: Tempering the SPAC Hype

June 4, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli

Please join your favorite SPAC corporate attorneys, Tom Burton, Sahir Surmeli, and Jeff Schultz as they set the record straight on SPACs’ apparent boom and bust, heavily reported on in the media.
Read more

SPAC Chat Ep. 4: Litigation Update: Preparing for the Next Wave of Suits Against SPACs

April 27, 2021 | Podcast | By Jeffrey Schultz, Sahir Surmeli

It seems that everyone is taking a second look at SPACs as the number of lawsuits against these alternative IPOs continues to increase by the day.
Read more

SPAC Chat Ep. 3: Tracking Trends of the SPAC Surge

March 29, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli

There is no denying the surge in special purpose acquisition companies (SPACs) and that these financing vehicles have had a significant impact on financial markets.
Read more

SPAC Chat Ep. 2: The Controversy Over Sponsor Equity

March 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli

Does a minimal investment in a Special Purpose Acquisition Company (SPAC) entitle a sponsor to a tremendous amount of equity after a successful IPO?
Read more

SPAC Chat: Busting Common Myths about SPACs

February 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli

Special Purpose Acquisition Companies (SPACs) are taking over Wall Street as more and more companies are taking advantage of this alternative IPO strategy.
Read more
Read less

News & Press

Press Release Thumbnail
BOSTON – Mintz advised NET Power, LLC, a clean energy technology company whose proprietary technology delivers clean, reliable and low-cost power from natural gas, in its planned business combination with Rice Acquisition Corp II (NYSE: RONI), a special purpose acquisition company (SPAC).
News Thumbnail
Mintz Member Jeffrey Schultz spoke to Law360 about the current SPAC market and how to get these deals across the finish line.
Mintz attorneys completed a $24.5 million financing in a private placement of common stock and warrants exercisable for common stock on behalf of Neutotrope, Inc., a company focused on developing drugs to treat neurodegenerative diseases including Alzheimer's disease.
Mintz Member Jeffrey Schultz is quoted in this Law360 column on the shortage of IPOs in January, which heavily impacts private companies considering public offerings as well as public companies seeking to meet their capital needs.
Read less

Events & Speaking


Seminar on Collaborative PIPEs

Johnson & Johnson Annual Investment Team Meeting

San Diego, CA


Lunch and Learn with Johnson & Johnson Innovation

1 Johnson & Johnson Plaza, New Brunswick, NJ

Read less

Jeffrey P. Schultz


New York